ARQT
Arcutis Biotherapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$23.90
+1.01%0
Insider buys (3m)
13
Insider sells (3m)
-$1.8M
Net value (3m)
+12.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 28, 2026 | Curran Terrie · director | Sale | 27,052 | $25 |
| Aug 28, 2026 | Curran Terrie · director | M-Exempt | 27,052 | $8.63 |
| Aug 28, 2026 | Curran Terrie · director | M-Exempt | 11,148 | $7.51 |
| Aug 24, 2026 | Curran Terrie · director | Sale | 1,072 | $26 |
| Aug 24, 2026 | Curran Terrie · director | M-Exempt | 1,072 | $7.51 |
| Aug 21, 2026 | Burnett Patrick · officer: See Remarks | Sale | 1,697 | $27 |
| Aug 19, 2026 | Welgus Howard G. · director | M-Exempt | 822 | $6.52 |
| Aug 19, 2026 | Welgus Howard G. · director | Sale | 4,730 | $26 |
| Aug 19, 2026 | Welgus Howard G. · director | M-Exempt | 1,019 | $7.51 |
| Aug 19, 2026 | Welgus Howard G. · director | M-Exempt | 2,255 | $8.63 |
| Aug 13, 2026 | Burnett Patrick · officer: See Remarks | M-Exempt | 8,300 | $3.64 |
| Aug 13, 2026 | Burnett Patrick · officer: See Remarks | M-Exempt | 6,700 | $3.64 |
| Aug 13, 2026 | Burnett Patrick · officer: See Remarks | Sale | 8,300 | $27 |
| Aug 13, 2026 | Burnett Patrick · officer: See Remarks | Sale | 6,700 | $26 |
| Aug 5, 2026 | Watanabe Todd · director, officer: See Remarks | Sale | 4,375 | $26 |
| Aug 5, 2026 | Matsuda Masaru · officer: See Remarks | Sale | 1,230 | $26 |
| Aug 5, 2026 | Burnett Patrick · officer: See Remarks | Sale | 955 | $26 |
| Jul 17, 2026 | Peetz Christopher · director | A-Award | 4,315 | $0.00 |
| Jul 17, 2026 | Welgus Howard G. · director | Sale | 4,730 | $27 |
| Jul 17, 2026 | Peetz Christopher · director | A-Award | 13,010 | $28 |
| Jul 17, 2026 | Welgus Howard G. · director | M-Exempt | 822 | $6.52 |
| Jul 17, 2026 | Welgus Howard G. · director | M-Exempt | 1,019 | $7.51 |
| Jul 17, 2026 | Peetz Christopher · director | A-Award | 21,486 | $28 |
| Jul 17, 2026 | Welgus Howard G. · director | M-Exempt | 2,255 | $8.63 |
| Jun 17, 2026 | Welgus Howard G. · director | Sale | 635 | $26 |
| Jun 17, 2026 | Welgus Howard G. · director | M-Exempt | 822 | $6.52 |
| Jun 17, 2026 | Welgus Howard G. · director | M-Exempt | 1,019 | $7.51 |
| Jun 17, 2026 | Welgus Howard G. · director | M-Exempt | 2,255 | $8.63 |
| Jun 17, 2026 | LIN SUE-JEAN · director | Sale | 4,946 | $24 |
| Jun 17, 2026 | Welgus Howard G. · director | Sale | 4,096 | $24 |
Institutional positioning
13F filings over the trailing two quarters
New 85Increased 197Reduced 191Sold out 37
| Filer | Action | Shares | Filed |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | Increased | 12,437,000 | Aug 14, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Increased | 12,327,000 | May 15, 2026 |
| BlackRock, Inc. | Increased | 10,545,466 | Aug 7, 2026 |
| Frazier Life Sciences Management, L.P. | Unchanged | 9,874,511 | Aug 14, 2026 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | Unchanged | 9,874,511 | May 15, 2026 |
| BLACKROCK, INC. | Increased | 9,200,411 | May 13, 2026 |
| Rubric Capital Management LP | Unchanged | 8,271,577 | Aug 14, 2026 |
| RUBRIC CAPITAL MANAGEMENT LP | Unchanged | 8,271,577 | May 15, 2026 |
| Polar Capital Holdings Plc | Increased | 6,606,945 | Aug 14, 2026 |
| STATE STREET CORP | Increased | 6,296,197 | May 15, 2026 |
| STATE STREET CORP | Reduced | 5,822,840 | Aug 7, 2026 |
| POLAR CAPITAL HOLDINGS PLC | Increased | 5,666,940 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 4,988,756 | Aug 13, 2026 |
| JENNISON ASSOCIATES LLC | Reduced | 4,980,770 | May 6, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 4,871,536 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 28, 2026